Chromophobe and Oncocytic Tumor Alliance announced collaboration with AACR to support early-career researchers in kidney cancer
Chromophobe and Oncocytic Tumor Alliance shared a post on X:
“We are excited to announce our collaboration with American Association for Cancer Research to support early-career researchers. Together, we are committed to the future of kidney cancer research.
Apply Now to the Scholars in Training Award— don’t miss this opportunity.”
Katie Coleman reshared the post on X, adding:
“OPEN NOW I am incredibly excited for this program and collaboration with AACR! As a collective, many of the kidney cancer nonprofits have come together to fund a group of SITA awards specifically for kidney cancer.
There will be approx 10 awards in total, ranging from clear cell to the rare histologies. Deadlines are approaching soon, so be sure to share and apply!
Stay tuned for more details from the other supporting organizations as well.”
Katie Coleman, Product and Engineering Lead at the Rare Cancer Research Foundation and President of the Chromophobe and Oncocytic Tumor Alliance (COA), is a dedicated software engineer with a mission for creating intuitive, user-friendly products. As a rare kidney cancer survivor, she is deeply committed to medical research and advocacy. Her personal experience helps her to promote collaborations that advance rare cancer research. Katie combines her technical expertise and unique perspective to develop products that improve patient outcomes and support the foundation’s mission.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023